Integra Launches AmnioExcel Placental Allograft Membrane
Zacks Investment Research | Feb 27, 2020 08:05PM ET
Integra LifeSciences (NASDAQ:IART) recently launched the AmnioExcel Plus Placental Allograft Membrane. This product, launched under the company’ wound care portfolio, is designed to aid the repair of soft tissue.
The launch is expected to boost the company’s Orthopedics and Tissue Technologies (“OTT”) segment.
More About the Product
AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft constituting of amnion-chorion-amnion layers that enables the process of complex wound closure. The proprietary DryFlex processing technology conserves the characteristic growth factors, cytokines and extracellular matrix found in native placental tissue. The room temperature storage, the five-year durability and convenience of use make it a superior product.
AmnioExcel Plus is a novel technology utilized by physicians in both the operating room and outpatient wound care setting, and is equipped to cater to around 8.2 million wounds with an estimated cost to Medicare of up to $98.6 billion annually.
Market Prospects
Per Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.